GO:0001792 polymeric immunoglobulin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001792 (polymeric immunoglobulin receptor activity) is a molecular function defined as binding J-chain-containing polymeric IgA or IgM via the Fc region and transmitting a signal across the membrane to initiate a change in cell activity.
• The polymeric immunoglobulin receptor (pIgR) mediates transcytosis of secretory IgA and IgM across mucosal epithelia, a central mechanism of mucosal immunity.
• pIgR is expressed in epithelial cells of the liver, salivary glands, intestine, and biliary tract, and its expression is regulated by microbiota and cholinergic signals.
• pIgR and secretory immunoglobulins are implicated in biliary atresia, primary biliary cholangitis, IgA nephropathy, thrombosis, and mucosal infections.
• Comparative studies show that pIgR function is conserved between fish and mammals, making it a tractable evolutionary and functional model.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect pIgR-dependent signaling and transport in human disease contexts.
Description
The polymeric immunoglobulin receptor (pIgR) is a transmembrane glycoprotein that binds polymeric immunoglobulins of the IgA and IgM isotypes and transports them across epithelial cells. In the Gene Ontology, this function is captured by GO:0001792, polymeric immunoglobulin receptor activity, a molecular function that combines with a J-chain-containing polymeric immunoglobulin via the Fc region and transmits a signal from one side of the membrane to the other to initiate a change in cell activity. This activity is essential for the formation of secretory IgA (SIgA) and secretory IgM (SIgM), which are key effectors of mucosal immunity. Researchers study GO:0001792 to understand how epithelial cells coordinate immune surveillance, how pathogens evade mucosal defenses, and how defects in this pathway contribute to diseases such as biliary atresia, primary biliary cholangitis, and IgA nephropathy. The receptor is also a target of regulation by microbiota and cholinergic signals, linking host immunity to environmental cues. Because pIgR is conserved across vertebrates, including fish and mammals, it provides a valuable model for comparative immunology and for testing gene-editing strategies.
polymeric immunoglobulin receptor activity At A Glance
| GO ID | GO:0001792 |
|---|---|
| GO term | polymeric immunoglobulin receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Combining with a J-chain-containing polymeric immunoglobulin of the IgA or IgM isotypes via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Binding and transcytosis of polymeric IgA and IgM across epithelial cells, forming secretory immunoglobulins. |
| Ligand specificity | J-chain-containing polymeric IgA or IgM, via the Fc region. |
| Cellular location | Transmembrane receptor on epithelial cells; also found in liver, salivary glands, intestine, and biliary tract. |
| Regulation | Modulated by microbiota and cholinergic signals. |
What Is GO:0001792?
GO:0001792, polymeric immunoglobulin receptor activity, is defined as the molecular function of combining with a J-chain-containing polymeric immunoglobulin of the IgA or IgM isotypes via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. In practice, this activity is carried out by the polymeric immunoglobulin receptor (pIgR), which binds dimeric IgA or pentameric IgM containing the J-chain, undergoes transcytosis, and releases the immunoglobulin as a secretory component-bound complex at the apical surface. This function is distinct from general immunoglobulin binding because it specifically requires polymeric, J-chain-containing ligands and results in signal transmission across the membrane.
Why Is polymeric immunoglobulin receptor activity Important in Cell Biology?
GO:0001792 is important because it governs the first step in the formation of secretory IgA and IgM, which are the primary antibodies protecting mucosal surfaces against pathogens. Disruption of this activity is associated with impaired mucosal immunity, increased susceptibility to infection, and inflammatory diseases such as biliary atresia and primary biliary cholangitis. In IgA nephropathy, aberrant IgA handling and B-cell targeting are linked to disease pathogenesis, highlighting the clinical relevance of pIgR-mediated transport. Moreover, pIgR and complement-driven mechanisms contribute to thrombosis, expanding the importance of this activity beyond classical mucosal immunity. Because pIgR is conserved in fish and mammals, it also serves as a model for studying the evolution of mucosal immunity and for developing CRISPR-based disease models.
• pIgR activity is essential for transcytosis of polymeric IgA and IgM, forming secretory immunoglobulins that neutralize pathogens at mucosal surfaces.
• It is a key mediator of mucosal immunity in the intestine, salivary glands, and biliary tract.
• Dysregulation of pIgR is implicated in biliary atresia, where it promotes Th2 immune responses via cholangiocyte-derived IL-33.
• pIgR and secretory immunoglobulins are involved in primary biliary cholangitis, with unique DUOX2+ACE2+ small cholangiocytes as pathogenic targets.
• In IgA nephropathy, B-cell targeting and IgA handling are therapeutic strategies linked to pIgR function.
• Antibodies and complement, including pIgR-related pathways, are drivers of thrombosis.
• pIgR expression is regulated by microbiota and cholinergic signals, linking host immunity to environmental factors.
• Comparative studies between fish and mammals reveal conserved and divergent features of pIgR.
• CRISPR knockout and knock-in models enable functional dissection of pIgR in human disease contexts.
What Happens During polymeric immunoglobulin receptor activity?
Ligand binding and recognition
In simple terms: The receptor grabs onto polymeric antibodies that contain a J-chain.
The polymeric immunoglobulin receptor (pIgR) specifically binds J-chain-containing polymeric IgA or IgM via the Fc region. This binding is the first step in the activity and ensures that only polymeric immunoglobulins, not monomeric IgG, are recognized. The interaction is non-covalent and occurs at the basolateral surface of epithelial cells.
Transcytosis across the epithelium
In simple terms: The receptor carries the antibody through the cell to the other side.
After binding, the pIgR-ligand complex is internalized and transported across the epithelial cell in a process called transcytosis. This transport is essential for delivering polymeric immunoglobulins from the basolateral to the apical surface, where they are released as secretory IgA or IgM. The process is conserved in mucosal tissues such as the intestine and salivary glands.
Signal transmission and cellular response
In simple terms: The receptor sends a signal into the cell after binding.
According to the GO definition, pIgR activity transmits a signal from one side of the membrane to the other to initiate a change in cell activity. This signaling can influence epithelial cell responses, including cytokine production and immune cell recruitment. In biliary atresia, pIgR promotes Th2 immune responses by increasing cholangiocyte-derived IL-33.
Release of secretory immunoglobulin
In simple terms: The antibody is released outside the cell, still attached to part of the receptor.
Following transcytosis, the extracellular domain of pIgR is cleaved, releasing the immunoglobulin bound to the secretory component. This secretory IgA or IgM complex is then free to neutralize pathogens in mucosal secretions. The released secretory component also protects the immunoglobulin from degradation.
Key Genes Involved in GO:0001792 polymeric immunoglobulin receptor activity
The following genes and proteins are central to polymeric immunoglobulin receptor activity and its regulation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGR | Encodes the polymeric immunoglobulin receptor that binds J-chain-containing IgA/IgM and mediates transcytosis. | Core gene for GO:0001792; knockout and knock-in models reveal transport and signaling functions. |
| JCHAIN | Encodes the J-chain that links IgA and IgM monomers into polymeric forms recognized by pIgR. | Essential for ligand formation; mutations affect pIgR binding. |
| IL33 | Cholangiocyte-derived cytokine increased by pIgR signaling in biliary atresia. | Links pIgR activity to Th2 immune responses and disease biomarkers. |
| DUOX2 | Marker of small cholangiocytes targeted in primary biliary cholangitis. | Used to identify pathogenic epithelial subsets interacting with pIgR. |
| ACE2 | Co-marker with DUOX2 in small cholangiocytes. | Relevant for epithelial targeting and pIgR-related disease models. |
| C3 | Complement component involved in antibody-driven thrombosis. | Connects pIgR-related antibody pathways to complement activation. |
| C5 | Complement component driving thrombosis with antibodies. | Potential target in pIgR-associated thrombotic models. |
| FCGR2A | Fc receptor for IgA/IgG involved in immune complex handling. | Relevant to IgA nephropathy and B-cell targeting. |
| CD20 | B-cell marker targeted in IgA nephropathy therapy. | Used in B-cell depletion studies linked to IgA handling. |
| CHRM3 | Cholinergic receptor mediating pIgR expression in Caco-2 cells. | Regulation of pIgR by cholinergic signals. |
| CHRNA7 | Cholinergic receptor potentially involved in pIgR regulation. | Studied in Caco-2 models of pIgR expression. |
| TLR4 | Microbiota-sensing receptor influencing postnatal salivary immunity. | Links microbiota to pIgR-dependent salivary immunity. |
| MYD88 | Adaptor in TLR signaling affecting mucosal immunity. | Potential regulator of pIgR expression via microbiota. |
| NOD2 | Intracellular sensor of microbiota. | May influence pIgR-mediated salivary immunity. |
| IL17A | Cytokine involved in mucosal immunity. | Modulates pIgR and secretory immunoglobulin responses. |
| TNF | Pro-inflammatory cytokine affecting epithelial barrier. | Regulates pIgR expression in inflammatory conditions. |
| IFNG | Cytokine that can upregulate pIgR in epithelial cells. | Used to study pIgR regulation in vitro. |
| IL4 | Th2 cytokine linked to pIgR-mediated IL-33 responses. | Relevant to biliary atresia Th2 inflammation. |
How Is polymeric immunoglobulin receptor activity Regulated?
Polymeric immunoglobulin receptor activity is regulated at multiple levels. Microbiota-dependent and -independent signals control postnatal development of salivary immunity, affecting pIgR expression. Cholinergic regulation of pIgR expression has been demonstrated in Caco-2 cells, where cholinergic agonists modulate receptor levels. Cytokines such as IFN-gamma and TNF can influence pIgR expression in epithelial cells. In biliary atresia, pIgR promotes Th2 immune responses by increasing cholangiocyte-derived IL-33, indicating regulation by inflammatory cues. These regulatory mechanisms ensure that pIgR activity is tuned to environmental and immune demands.
polymeric immunoglobulin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGR | Biliary atresia; promotes Th2 response via IL-33 | Knockout and overexpression in cholangiocyte cell lines and mouse models |
| DUOX2/ACE2 | Primary biliary cholangitis; pathogenic small cholangiocytes | Knock-in reporters and organoid models |
| FCGR2A/CD20 | IgA nephropathy; B-cell targeting | B-cell depletion and IgA transport assays |
| C3/C5 | Thrombosis; complement activation | Complement knockout models and thrombosis assays |
| PIGR | Mucosal infection and immunity | Epithelial cell knockout and infection challenge models |
Biliary atresia
Polymeric immunoglobulin receptor activity promotes Th2 immune responses in the liver by increasing cholangiocyte-derived IL-33, and it has been proposed as a diagnostic and therapeutic biomarker of biliary atresia. This links pIgR function directly to pediatric liver disease and mucosal immune dysregulation.
Primary biliary cholangitis
Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets in primary biliary cholangitis, and pIgR-related pathways may influence epithelial immune responses in this disease. The identification of these cells provides a model to study pIgR activity in biliary inflammation.
IgA nephropathy
B-cell targeting in IgA nephropathy highlights the importance of IgA handling, in which pIgR-mediated transport plays a central role. Therapeutic strategies that deplete B cells may indirectly affect pIgR-dependent IgA clearance.
Thrombosis and complement
Antibodies and complement are key drivers of thrombosis, and pIgR-related antibody pathways may contribute to this process. This expands the disease relevance of GO:0001792 beyond mucosal immunity to vascular pathology.
From polymeric immunoglobulin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of pIgR affect IgA transcytosis? | PIGR knockout epithelial cell lines (e.g., Caco-2) |
| Can a point mutation in PIGR alter ligand binding? | Point-mutation knock-in via CRISPR in epithelial cells |
| How does pIgR signaling induce IL-33? | Knock-in reporter of IL33 in cholangiocytes |
| What is the effect of pIgR overexpression on mucosal immunity? | Overexpression of PIGR in mouse salivary glands |
| Which genes regulate pIgR expression? | CRISPR library screening in Caco-2 cells |
| How does microbiota influence pIgR? | Germ-free and conventionalized mouse models |
How to Study the polymeric immunoglobulin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | PIGR mRNA expression and transcriptome changes | Tissue-specific regulation and microbiota effects |
| Western blot | pIgR protein levels and cleavage | Validation of knockout or overexpression |
| Confocal microscopy | Transcytosis of IgA/pIgR complexes | Polarized epithelial cell studies |
| ELISA | Secretory IgA/IgM production | Functional assessment of pIgR activity |
| CRISPR knockout | Loss-of-function phenotypes | Causal testing of PIGR in disease models |
| CRISPR knock-in | Tagged or mutant pIgR | Tracking and signaling studies |
| Library screening | Genes regulating pIgR expression | High-throughput discovery |
| Organoid culture | Epithelial transport in 3D | Cholangiocyte and intestinal models |
Transcriptomic analysis of pIgR expression
RNA-seq can quantify PIGR mRNA levels across tissues and conditions, revealing regulation by microbiota and cholinergic signals. This method is useful for identifying co-expressed genes and pathways linked to GO:0001792.
Proteomic and immunoblot detection of pIgR
Western blotting and mass spectrometry can detect pIgR protein and its cleavage products, including the secretory component. These methods confirm transcytosis and ligand binding in epithelial cells.
Imaging of transcytosis
Confocal microscopy and live-cell imaging using fluorescently tagged IgA or pIgR can visualize transport from basolateral to apical surfaces. This provides direct evidence of pIgR activity in polarized cells.
Functional assays for secretory immunoglobulin production
ELISA and neutralization assays measure secretory IgA and IgM released after pIgR-mediated transcytosis. These assays are used to test the impact of gene editing on pIgR function.
How CRISPR Can Be Used to Study GO:0001792 polymeric immunoglobulin receptor activity
Knockout
CRISPR knockout of PIGR in epithelial cell lines or organoids can abolish polymeric immunoglobulin receptor activity, leading to defective IgA transcytosis and reduced secretory immunoglobulin production. Such models are used to test the causal role of pIgR in biliary atresia and mucosal immunity.
Point Mutation
Point mutations in the ligand-binding domain of PIGR can be introduced via CRISPR to dissect residues required for J-chain-containing IgA/IgM recognition. These models help distinguish binding from downstream signaling.
Knock-in
Knock-in of fluorescent or epitope tags into the endogenous PIGR locus allows real-time tracking of receptor trafficking and transcytosis. This approach is valuable for studying pIgR in primary cholangiocytes and intestinal cells.
Overexpression
CRISPR-mediated overexpression of PIGR in mouse salivary glands or liver can enhance secretory immunoglobulin production and modulate immune responses. Overexpression models are useful for testing therapeutic potential in mucosal infections.
How EDITGENE Supports polymeric immunoglobulin receptor activity Research
Researchers studying polymeric immunoglobulin receptor activity-related genes often need to determine whether a candidate gene is causally involved in IgA/IgM transport, epithelial signaling, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling functional validation of GO:0001792 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for polymeric immunoglobulin receptor activity research.
Frequently Asked Questions About polymeric immunoglobulin receptor activity
What is polymeric immunoglobulin receptor activity?
It is the molecular function defined by GO:0001792, where the polymeric immunoglobulin receptor binds J-chain-containing IgA or IgM via the Fc region and transmits a signal across the membrane to initiate a change in cell activity.
What genes are involved in polymeric immunoglobulin receptor activity?
The core gene is PIGR, which encodes the receptor; JCHAIN is required for ligand formation, and cytokines such as IL33 and regulators like DUOX2 and ACE2 are involved in related pathways.
What is the GO ID for polymeric immunoglobulin receptor activity?
The GO ID is GO:0001792, under the molecular_function ontology.
How is polymeric immunoglobulin receptor activity regulated?
It is regulated by microbiota, cholinergic signals, and cytokines such as IFN-gamma and TNF, as shown in salivary and intestinal models.
What diseases are associated with polymeric immunoglobulin receptor activity?
It is associated with biliary atresia, primary biliary cholangitis, IgA nephropathy, thrombosis, and mucosal infections.
What is the role of pIgR in mucosal immunity?
pIgR mediates transcytosis of polymeric IgA and IgM, forming secretory immunoglobulins that neutralize pathogens at mucosal surfaces.
Can CRISPR be used to study polymeric immunoglobulin receptor activity?
Yes, CRISPR knockout, knock-in, and overexpression models are used to dissect pIgR function and its role in disease.
Which cell types express the polymeric immunoglobulin receptor?
It is expressed in epithelial cells of the intestine, salivary glands, liver, and biliary tract, including cholangiocytes.
What is the difference between pIgR and secretory component?
The secretory component is the cleaved extracellular domain of pIgR that remains bound to IgA or IgM after transcytosis.
How can I measure polymeric immunoglobulin receptor activity?
Methods include RNA-seq, Western blot, confocal imaging of transcytosis, and ELISA for secretory IgA/IgM.
Conclusion
GO:0001792, polymeric immunoglobulin receptor activity, is a molecular function essential for mucosal immunity through the binding and transcytosis of J-chain-containing polymeric IgA and IgM. Its roles in biliary atresia, primary biliary cholangitis, IgA nephropathy, and thrombosis highlight its broad clinical relevance. Understanding its regulation by microbiota and cholinergic signals provides opportunities for therapeutic intervention. CRISPR-based models from EDITGENE can accelerate functional studies and drug target validation for this important pathway.
References
- 1. Li Y et al.. 2024. Polymeric immunoglobulin receptor promotes Th2 immune response in the liver by increasing cholangiocytes derived IL-33: a diagnostic and therapeutic biomarker of biliary atresia.. EBioMedicine 108:105344 PMID: 39288533
- 2. Stark K et al.. 2024. Antibodies and complement are key drivers of thrombosis.. Immunity 57(9):2140-2156.e10 PMID: 39226900
- 3. Zubeidat K et al.. 2023. Microbiota-dependent and -independent postnatal development of salivary immunity.. Cell Rep 42(1):111981 PMID: 36640306
- 4. Li X et al.. 2023. Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis.. Nat Commun 14(1):29 PMID: 36759512
- 5. Kong X et al.. 2018. Comparison of polymeric immunoglobulin receptor between fish and mammals.. Vet Immunol Immunopathol 202:63-69 PMID: 30078600
- 6. Turula H et al.. 2018. The Role of the Polymeric Immunoglobulin Receptor and Secretory Immunoglobulins during Mucosal Infection and Immunity.. Viruses 10(5) PMID: 29751532
- 7. Suzuki Y. 2024. B cell targeting in IgA nephropathy.. Nephrology (Carlton) 29 Suppl 2:39-43 PMID: 39327767
- 8. Higuera-Martínez G et al.. 2025. Cholinergic regulation on polymeric immunoglobulin receptor expression in Caco-2 cells.. Acta Pharm 75(3):547-555 PMID: 41190722
